Du-Zhong (Eucommia ulmoides Oliv.) cortex extract prevent OVX-induced osteoporosis in rats

Bone

Volumn 45, Issue 3, 2009, Pages 553-559

  Zhang, R ^a   Liu, Z G ^a   Li, C ^a   Hu, S J ^b   Liu, L ^a   Wang, J P ^a   Mei, Q B ^a,c  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c NORTHWESTERN POLYTECHNICAL UNIVERSITY   (China)

Author keywords

Bone turnover; Du Zhong (Eucommia ulmoides Oliv.); DXA and CT; Mechanical test; Ovariectomy

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; DEOXYPYRIDINOLINE; ETHINYLESTRADIOL; EUCOMMIA ULMOIDES EXTRACT; OSTEOCALCIN; PHOSPHORUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE DENSITY; BONE MASS; BONE REMODELING; BONE STRESS; BONE TURNOVER; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; ESTROGEN DEFICIENCY; EUCOMMIACEAE; FEMALE; METAPHYSIS; NONHUMAN; OVARIECTOMY; POSTMENOPAUSE OSTEOPOROSIS; RAT; TRABECULAR BONE; TU CHUNG; YOUNG MODULUS;

ANIMALS; BIOLOGICAL MARKERS; BONE DENSITY; DRUGS, CHINESE HERBAL; EUCOMMIACEAE; FEMALE; FEMUR; OSTEOPOROSIS; OVARIECTOMY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 67949120224     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2008.08.127     Document Type: Article

References (66)

1. Garnero P., and Delmas P.D. Osteoporosis. Endocrinol. Metab. Clin. North. Am. 26 (1997) 913-936
2. Hans D., Fuerst T., Lang T., Majumdar S., Lu Y., Genant H.K., et al. How can we measure bone quality?. Baillieres. Clin. Rheumatol. 11 (1997) 495-515
3. Stevenson J.C. Justification for the use of HRT in the long-term prevention of osteoporosis. Maturitas 51 (2005) 113-126
4. Prelevic G.M., Kocjan T., and Markou A. Hormone replacement therapy in postmenopausal women. Minerva. Endocrinol. 30 (2005) 27-36
5. Davison S., and Davis S.R. Hormone replacement therapy: current controversies. Clin. Endocrinol. 58 (2003) 249-261
6. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
7. Kessel B. Alternatives to estrogen for menopausal women. Proc. Soc. Exp. Biol. Med. 217 (1998) 38-44
8. Beckman N. Phyto-oestrogens and compounds that affect oestrogen metabolism. Australian. Journal of Medical Herbalism 7 (1995) 11-16
9. Kühnau J. The flavonoids. A class of semi-essential food components: their role in human nutrition. World Rev. Nutr. Diet. 24 (1976) 117-191
10. Setchell K.D. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am. J. Clin. Nutr. 68 Suppl 6 (1998) 1333S-1346S
11. Arjmandi B.H., Alekeel L., Hollis B.W., Amin D., Stacewicz Sapuntzakis M., Guo P., et al. Dietary soybean prevents bone loss in an ovariectomized rat model of osteoporosis. J. Nutr. 126 (1996) 161-167
12. Arjmandi B.H., Birnbaum R., Goyal N.V., Getlinger M.J., Juma S., Alekeel L., et al. Bone-sparing effect of soy protein in ovarian hormonedeficient rats is related to its isoflavone content. Am. J. Clin. Nutr. 68 Suppl 6 (1998) 1364S-1368S
13. Arjmandi B.H., Getlinger M.J., Goyal N.V., Hasler C.M., Juma S., Drum M.L.H., et al. Role of soy protein with normal or reduced isoflavone content in reversing bone loss induced by ovarian deficiency in rats. Am. J. Clin. Nutr. 68 Suppl 6 (1998) 1858S-1863S
14. Draper C.R., Edel M.J., Dick I.M., Randall A.G., Martin G.B., and Prince R.L. Phytoestrogens reduce bone loss and bone resorption in oophorectomized rats. J. Nutr. 127 (1997) 1795-1799
15. Potter S.M., Baum J.A., Teng H., Stillman R.J., Shays N.F., and Erdman J.W. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am. J. Clin. Nutr. 68 Suppl 6 (1998) 1375S-1379S
16. Cosman F., and Lindsay R. Selective estrogen receptor modulators: clinical spectrum. Endocr. Rev. 20 (1999) 418-434
17. Brezinski A., and Debi A. Phytoestrogens: the "natural" selective estrogen receptor modulators. Eur. J. Obstet. Gynecol. Reprod. Biol. 85 (1999) 47-51
18. Kim M.K., Chung B.C., Yu V.Y., Nam J.H., Lee H.C., Huh K.B., et al. Relationships of urinary phytoestrogen excretion to BMD in postmenopausal women. Clin. Endocrinol. (Oxf). 56 (2002) 321-328
19. Yin J., Tezuka Y., Subehan, Shi L., Nobukawa M., Nobukawa T., et al. In vivo anti-osteoporotic activity of isotaxiresinol, a lignan from wood of Taxus yunnanensis. Phytomedicine 13 (2006) 37-42
20. Lee M.K., Yang H., Ma C.J., and Kim Y.C. Stimulatory activity of lignans from Machilus thunbergii on osteoblast differentiation. Biol. Pharm. Bull 30 (2007) 814-817
21. Horcajada-Molteni M.N., Crespy V., Coxam V., Davicco M.J., Rémésy C., and Barlet J.P. Rutin inhibits ovariectomy-induced osteopenia in rats. J. Bone Miner. Res. 15 (2000) 2251-2258
22. Kawasaki T., Uezono K., and Nakazawa Y. Antihypertensive mechanism of food for specified health use. "Eucommia leaf glycoside" and its clinical application. J. Health Sci. 22 (2000) 29-36
23. Deyama T., Nishibe S., and Nakazawa Y. Constituents and pharmacological effects of Eucommia and Siberian ginseng. Acta. Pharmacol. Sin. 22 (2001) 1057-1070
24. Li Z.L., Cui K.M., Yuan Z.D., and Liu S. Regeneration of recovered bark in Eucommia ulmoides. Chem. Biol. Agric. Med. Earth. Sci. 26 (1983) 33-40
25. Kalu D.N. The ovariectomized rat model of postmenopausal bone loss. Bone Miner. 15 (1991) 175-191
26. Thompson D.D., Simmons H.A., Pirie C.M., and Ke H.Z. FDA Guidelines and animal models for osteoporosis. Bone 17 Suppl 4 (1995) 125S-133S
27. Wronski T.J., Schenck P.A., Cintrón M., and Walsh C.C. Effect of body weight on osteopenia in ovariectomized rats. Calcif. Tissue Int. 40 (1987) 155-159
28. FDA Guidance for industry and reviews 2002: estimating the safe starting dose in clinical trials for therapeutics in adult healthy volunteers 12.
29. Huang J.H., Huang X.H., Chen Z.Y., et al. Dose conversion among different animals and healthy volunteers in pharmacological study. Chin. J. Clin. Pharmacol. Ther. 9 (2004) 1069-1072
30. National Research Council 1996: Guide for the Care and Use of Laboratory Animals.
31. Arjmandi B.H., Lucas E.A., Juma S., Soliman A., Stoecker B.J., Khalil D.A., et al. Dried plums prevent ovariectomy-induced bone loss in rats. JANA 4 (2001) 50-56
32. Qin L., Zhang G., Shi Y.Y., Lee K.M., and Leung P.C. Prevention and treatment of osteoporosis with traditional herbal medicine. In: Deng H.W. (Ed). Current topics of osteoporosis (2005), World Scientific Publisher 513-531
33. Zhang G., Qin L., Hung W.Y., Shi Y.Y., Leung P.C., Yeung H.Y., et al. Flavonoids derived from herbal Epimedium Brevicornum Maxim prevent OVX-induced osteoporosis in rats independent of its enhancement in intestinal calcium absorption. Bone 38 (2006) 818-825
34. Morris H.A., Porter S.J., Durbridge T.C., Moore R.J., Need A.G., and Nordin B.E. Effects of oophorectomy on biochemical and bone variables in the rat. Bone Miner. 18 (1992) 133-142
35. Brown J.P., Delmas P.D., Malaval L., Edouard C., Chapuy M.C., and Meunier P.J. Serum bone GLA-protein: a specific marker for bone formation in postmenopausal osteoporosis. Lancet 1 (1984) 1091-1093
36. Meyer-Sabellek W., Sinha P., and Köttgen E. Alkaline phosphatase. Laboratory and clinical implications. J. Chromatogr. 429 (1988) 419-444
37. Ederveen A.G., Spanjers C.P., Quaijtaal J.H., and Kloosterboer H.J. Effect of 16 months of treatment with tibolone on bone mass, turnover, and biomechanical quality in mature ovariectomized rats. J. Bone Miner. Res. 16 (2001) 1674-1681
38. Raisz L.G. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J. Clin. Invest. 115 (2005) 3318-3325
39. Wronski T.J., Dann L.M., Scott K.S., and Crooke L.R. Endocrine and pharmacological suppressors of bone turnover protect against osteopenia in ovariectomised rats. Endocrinology 125 (1989) 810-816
40. Turner R.T., Vandersteenhove J.J., and Bell N.H. The effect of ovariectomy and 17beta-estradiol on bone histomorphometry in growing rats. J. Bone Miner. Res. 2 (1987) 115-122
41. Avioli L.V., Mcdonald J.E., and Singer R.A. Excretion of pyrophosphate in disorders of bone metabolism. J. Clin. Endocrinol. Metab. 25 (1965) 912-915
42. Gaumet N., Seibel M.J., Coxam V., Davicco M.J., Lebecque P., and Barlet J.P. Influence of ovariectomy and estradiol treatment on calcium homeostasis during aging in rats. Arch. Physiol. Biochem. 105 (1997) 435-444
43. Ferretti J.L., Cointry G., Capozza R., Montuori E., Roldan E., and Perez Lloret A. Biomechanical effects of the full range of useful doses of (3-amino-hydroxypropyliidene)-1, 1-bisphospho-nate (APD) on femur diaphyses and cortical bone tissue in rats. Bone Miner 11 (1990) 111-122
44. Bouxsein M.L. Mechanisms of osteoporosis therapy: a bone strength perspective. Clin. Cornerstone. Suppl 2 (2003) 13S-21S
45. Wronski T.J., Dann L.M., Scott K.S., and Cintrón M. Long-term effects of ovariectomy and aging on the rat skeleton. Calcif. Tissue Int. 45 (1989) 360-366
46. Ulrich D., van Rietbergen B., Laib A., and Ruegsegger P. The ability of three-dimensional structural indices to reflect mechanical aspects of trabecular bone. Bone 25 (1999) 55-60
47. Lane N.E., Kumer J.L., Majumdar S., Khan M., Lotz J., Stevens R.E., et al. The effects of synthetic conjugated estrogens, a (cenestin) on trabecular bone structure and strength in the ovariectomized rat model. Osteoporos. Int. 13 (2002) 816-823
48. Wronski T.J., Dann L.M., Scott K.S., and Cintrón M. Long-term effects of ovariectomy and aging on the rat skeleton. Calcif. Tissue Int. 45 (1989) 360-366
49. Laib A., Kumer J.L., Majumdar S., and Lane N.E. The temporal changes of trabecular architecture in ovariectomized rats assessed by MicroCT. Osteoporos. Int. 12 (2001) 936-941
50. Dang Z.C., van Bezooijen R.L., Karperien M., Papapoulos S.E., and Lowik C.W. Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis. J. Bone Miner. Res. 17 (2002) 394-405
51. Tchernof A., and Poehlman E.T. Effects of the menopause transition on body fatness and body fat distribution. Obes. Res. 6 (1998) 246-254
52. Joyner J.M., Hutley L.J., and Cameron D.P. Estrogen receptors in human preadipocytes. Endocrine 15 (2001) 225-230
53. Kähkönen M.P., Hopia A.I., Vuorela H.J., Rauha J.P., Pihlaja K., Kujala T.S., et al. Antioxidant activity of plant extracts containing phenolic compounds. J. Agric. Food Chem. 47 (1999) 3954-3962
54. Sugihara N., Arakawa T., Ohnishi M., and Furuno K. Anti- and pro-oxidative effects of flavonoids on metal induced lipid hydroperoxide dependent lipid peroxidation in cultured hepatocytes located with α-linolenic acid. Free Radic. Biol. Med. 27 (1999) 1313-1323
55. Sontakke A.N., and Tare R.S. A duality in the roles of reactive oxygen species with respect to bone metabolism. Clin. Chim. Acta. 318 (2002) 145-148
56. Mody N., Parhami F., Sarafian T.A., and Demer L.L. Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic. Biol. Med. 31 (2001) 509-519
57. BAi X.C., Lu D., Bai J., Zheng H., Ke Z.Y., Li X.M., et al. Oxidative stress inhibits osteoblastic differentiation of bone cells ERK and NF-Kappa B. Biochem. Biophys. Res. Commun. 314 (2004) 197-207
58. Eklund P.C., Långvik O.K., Wärnå J.P., Salmi T.O., Willför S.M., and Sjöholm R.E. Chemical studies on antioxidant mechanisms and free radical scavenging properties of lignans. Org. Biomol. Chem. 3 (2005) 3336-3347
59. Teixeira S., Siquet C., Alves C., Boal I., Marques M.P., Borges F., et al. Structure-property studies on the antioxidant activity of flavonoids present in diet. Free Radic. Biol. Med. 15 39 (2005) 1099-1108
60. Yen G.C., and Hsieh C.L. Inhibitory effects of Du-zhong (Eucommia ulmoides Oliv.) against low-density lipoprotein oxidative modification. Food Chem. 77 (2002) 449-456
61. Hsieh C.L., and Yen G.C. Antioxidant actions of Du-zhong (Eucommia ulmoides Oliv.) toward oxidative damage in biomolecules. Life Sci. 66 (2000) 1387-1400
62. Yen G.C., and Hsieh C.L. Inhibitory effect of Eucommia ulmoides Oliv. on oxidative DNA damage in lymphocytes induced by H2O2. Teratog. Carcinog. Mutagen. Suppl 1 (2003) 23S-34S
63. Lee M.K., Cho S.Y., Kim D.J., Jang J.Y., Shin K.H., Park S.A., et al. Du-zhong (Eucommia ulmoides Oliv.) cortex water extract alters heme biosynthesis and erythrocyte antioxidant defense system in lead-administered rats. J. Med. Food. 8 (2005) 86-92
64. Zava D.T., Dollbaum C.M., and Blen M. Estrogen and progestin bioactivity of foods, herbs, and spices. Proc. Soc. Exp. Biol. Med. 217 (1998) 369-378
65. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., Van Der Saag P.T., et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139 (1998) 4252-4263
66. Vidal O., Kindbom L.G., and Ohlsson C. Expression and localization of estrogen receptor-β in murine and human bone. J. Bone Miner Res. 14 (1998) 923-929